hiltonol
Showing 1 - 4 of 4
Glioma, Malignant Trial in Durham (Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine, Hiltonol)
Not yet recruiting
- Glioma, Malignant
- Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine
- Hiltonol
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center at Duke University
Jan 19, 2023
Breast Cancer Trial in Tampa, Boston, New York (PVX-410, Durvalumab, Hiltonol)
Active, not recruiting
- Breast Cancer
- PVX-410
- +2 more
-
Tampa, Florida
- +4 more
May 7, 2021
Smoldering Multiple Myeloma Trial in Boston, Durham, Cleveland (Hiltonol, Citarinostat, Lenalidomide)
Recruiting
- Smoldering Multiple Myeloma
- Hiltonol
- +3 more
-
Boston, Massachusetts
- +4 more
Feb 22, 2021
Squamous Cell Carcinoma of the Oral Cavity Trial in Worldwide (GL-0817, Hiltonol, Sargramostim)
Completed
- Squamous Cell Carcinoma of the Oral Cavity
- GL-0817
- +4 more
-
Baltimore, Maryland
- +32 more
Mar 4, 2022